Pitfalls and False Positives in Clinical FDG

In this abridgement, Daniel Pryma, MD, Clinical Director of Nuclear Medicine/Molecular Imaging at Penn Medicine, considers the anomalies associated with the analog fluorodeoxyglucose (FDG) when used in conjunction with PET/CT scanning. Dr. Pryma’s summary includes attenuation correction artifacts in high density materials, the false positives associated with interpretation technique in PET/CT and image registration (and misregistration) with the modality.

This video is an abridgement of Pitfalls and False Positives in Clinical FDG, a Health e Galaxy CME program available for DVD purchase or download at



August 24, 2015

Created by

Penn Physician VideoLink